516 related articles for article (PubMed ID: 11825096)
1. Drug interactions with patient-controlled analgesia.
Lotsch J; Skarke C; Tegeder I; Geisslinger G
Clin Pharmacokinet; 2002; 41(1):31-57. PubMed ID: 11825096
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
3. [Interaction of opioid analgesics at the level of biotransformation].
Petri H; Grandt D
Schmerz; 2016 Dec; 30(6):519-525. PubMed ID: 27439327
[TBL] [Abstract][Full Text] [Related]
4. Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.
Solhaug V; Molden E
Scand J Pain; 2017 Oct; 17():193-200. PubMed ID: 29054049
[TBL] [Abstract][Full Text] [Related]
5. The role of methadone in cancer pain treatment--a review.
Leppert W
Int J Clin Pract; 2009 Jul; 63(7):1095-109. PubMed ID: 19570126
[TBL] [Abstract][Full Text] [Related]
6. Opioid pharmacokinetic drug-drug interactions.
Overholser BR; Foster DR
Am J Manag Care; 2011 Sep; 17 Suppl 11():S276-87. PubMed ID: 21999760
[TBL] [Abstract][Full Text] [Related]
7. Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives.
Lötsch J; Skarke C; Liefhold J; Geisslinger G
Clin Pharmacokinet; 2004; 43(14):983-1013. PubMed ID: 15530129
[TBL] [Abstract][Full Text] [Related]
8. "Weak" opioid analgesics. Codeine, dihydrocodeine and tramadol: no less risky than morphine.
Prescrire Int; 2016 Feb; 25(168):45-50. PubMed ID: 27042732
[TBL] [Abstract][Full Text] [Related]
9. Potential P-glycoprotein pharmacokinetic interaction of telaprevir with morphine or methadone.
Fudin J; Fontenelle DV; Fudin HR; Carlyn C; Hinden DA; Ashley CC
J Pain Palliat Care Pharmacother; 2013 Aug; 27(3):261-7. PubMed ID: 23879227
[TBL] [Abstract][Full Text] [Related]
10. Non-analgesic effects of opioids: interactions between opioids and other drugs.
Heiskanen T; Kalso E
Curr Pharm Des; 2012; 18(37):6079-89. PubMed ID: 22747548
[TBL] [Abstract][Full Text] [Related]
11. Methadone Metabolism and Drug-Drug Interactions: In Vitro and In Vivo Literature Review.
Volpe DA; Xu Y; Sahajwalla CG; Younis IR; Patel V
J Pharm Sci; 2018 Dec; 107(12):2983-2991. PubMed ID: 30205091
[TBL] [Abstract][Full Text] [Related]
12. Clinically significant drug-drug interactions involving opioid analgesics used for pain treatment in patients with cancer: a systematic review.
Kotlinska-Lemieszek A; Klepstad P; Haugen DF
Drug Des Devel Ther; 2015; 9():5255-67. PubMed ID: 26396499
[TBL] [Abstract][Full Text] [Related]
13. CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants.
Haufroid V; Hantson P
Clin Toxicol (Phila); 2015 Jul; 53(6):501-10. PubMed ID: 25998998
[TBL] [Abstract][Full Text] [Related]
14. Dextromethorphan differentially affects opioid antinociception in rats.
Chen SL; Huang EY; Chow LH; Tao PL
Br J Pharmacol; 2005 Feb; 144(3):400-4. PubMed ID: 15655510
[TBL] [Abstract][Full Text] [Related]
15. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
16. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
Freye E; Latasch L
Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
[TBL] [Abstract][Full Text] [Related]
17. Loss of analgesic effect of morphine due to coadministration of rifampin.
Fromm MF; Eckhardt K; Li S; Schänzle G; Hofmann U; Mikus G; Eichelbaum M
Pain; 1997 Aug; 72(1-2):261-7. PubMed ID: 9272811
[TBL] [Abstract][Full Text] [Related]
18. Methadone: a review of drug-drug and pathophysiological interactions.
Kapur BM; Hutson JR; Chibber T; Luk A; Selby P
Crit Rev Clin Lab Sci; 2011; 48(4):171-95. PubMed ID: 22035341
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic optimisation of opioid treatment in acute pain therapy.
Upton RN; Semple TJ; Macintyre PE
Clin Pharmacokinet; 1997 Sep; 33(3):225-44. PubMed ID: 9314613
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication.
Kirchheiner J; Schmidt H; Tzvetkov M; Keulen JT; Lötsch J; Roots I; Brockmöller J
Pharmacogenomics J; 2007 Aug; 7(4):257-65. PubMed ID: 16819548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
